Health AI Central
Share:
Peer-Reviewed Publication
Prev Med2020;132105987.March 1, 2020Journal Article

Online patient-provider cannabis consultations.

Kathleen Gali1, Ruth Narode1, Kelly C Young-Wolff2, Mark L Rubinstein3, Geoffrey Rutledge4, Judith J Prochaska5
1Stanford University, Department of Medicine, Stanford Prevention Research Center, 1265 Welch Rd, Palo Alto, CA 94305, USA.
2Kaiser Permanente Northern California, Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
3University of California, San Francisco, Department of Pediatrics, 3333 California Street, San Francisco, CA 94118, USA.
4HealthTap, 2465 Latham Street, Mountain View, CA 94040, USA.
5Stanford University, Department of Medicine, Stanford Prevention Research Center, 1265 Welch Rd, Palo Alto, CA 94305, USA. Electronic address: jpro@stanford.edu.
PubMed PMC DOI PDF

Abstract

Cannabis has been legalized, decriminalized, or medicalized in over half the U.S. states. With restrictions on cannabis research, accepted standards to guide clinical practice are lacking. Analyzing online communications through a digital health platform, we characterized patient questions about cannabis use and provider responses. Coded for content were 4579 questions posted anonymously online be…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.